Technical Analysis for MRTX - Mirati Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 73.91 4.73% 3.34
MRTX closed up 4.73 percent on Friday, May 17, 2019, on 2.0 times normal volume.
6 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical MRTX trend table...

Date Alert Name Type % Chg
MACD Bullish Centerline Cross Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Multiple of Ten Bullish Other 0.00%
Inside Day Range Contraction 0.00%
Above Upper BB Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Shooting Star Candlestick Bearish 4.73%
Lizard Bearish Bearish Day Trade Setup 4.73%
Crossed Above 20 DMA Bullish 4.73%

Older signals for MRTX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:
Profile
Mirati Therapeutics Inc., a biopharmaceutical company, engages in the development of therapeutics for the cancer treatment. Its lead program in clinical development is MGCD265, a multi-targeted small molecule kinase inhibitor for treatment of oncology patients with solid tumors. The company also evaluates development opportunities in oncology for mocetinostat, a spectrum-selective HDAC inhibitor for the treatment of patients with myelodysplastic syndrome or lymphoma; and MGCD516, a kinase inhibitor with a target profile for the treatment of patients with non-small cell lung cancer and other solid tumors. Mirati Therapeutics Inc. is headquartered in San Diego, California.
Medicine Biopharmaceutical Cancer Chemical Compounds Solid Tumors Oncology Non Small Cell Lung Cancer Lymphoma Cancer Treatment Targeted Therapy Myelodysplastic Syndrome Bemcentinib
Is MRTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 17 63 Biggest Movers From Yesterday
May 16 5 ASCO Abstracts That Moved Stocks
May 16 Here's Why Mirati Therapeutics Is Surging Today
May 16 Microcaps mostly among midday movers
May 16 Here Are The Biotech Winners Ahead Of 2019's Biggest Cancer Meeting
May 16 Iovance Biotherapeutics leads healthcare gainers; EDAP TMS and Cellectar Biosciences among losers
May 16 What's Triggering The Rise In Mirati Shares?
May 16 GEVO, TRQ among premarket gainers
May 16 Mirati up 11% premarket on AMG 510 data
May 15 The Daily Biotech Pulse: FDA Greenlights Pfizer-Merck KGAa's Kidney Cancer Combo Treatment, Adcom Disappointment For Daiichi
See more MRTX news...
Indicators
Indicator Value
52 Week High 80.0
52 Week Low 28.5
Average Volume 622,574
200-Day Moving Average 56.5554
50-Day Moving Average 68.931
20-Day Moving Average 64.9295
10-Day Moving Average 67.697
Average True Range 4.5626
ADX 20.82
+DI 27.2063
-DI 14.6127
Chandelier Exit (Long, 3 ATRs ) 63.0022
Chandelier Exit (Short, 3 ATRs ) 68.7978
Upper Bollinger Band 72.1252
Lower Bollinger Band 57.7338
Percent B (%b) 1.12
BandWidth 22.164656
MACD Line 0.4766
MACD Signal Line -0.62
MACD Histogram 1.0966
Fundamentals Value
Market Cap 1.85 Billion
Num Shares 25 Million
EPS -3.38
Price-to-Earnings (P/E) Ratio -21.87
Price-to-Sales 0.00
Price-to-Book 3.81
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 81.17
Resistance 3 (R3) 80.57 77.55 79.96
Resistance 2 (R2) 77.55 75.70 77.85 79.56
Resistance 1 (R1) 75.73 74.56 76.64 76.33 79.15
Pivot Point 72.71 72.71 73.17 73.01 72.71
Support 1 (S1) 70.89 70.86 71.80 71.49 68.67
Support 2 (S2) 67.87 69.72 68.17 68.26
Support 3 (S3) 66.05 67.87 67.86
Support 4 (S4) 66.65